Body mass index and breast cancer survival: A Mendelian randomization analysis

International Journal of Epidemiology

Volumn 46, Issue 6, 2017, Pages 1891-1902

  Guo, Qi ^a   Burgess, Stephen ^a   Turman, Constance ^b   Bolla, Manjeet K ^a   Wang, Qin ^a   Lush, Michael ^a   Abraham, Jean ^a,c   Aittomäki, Kristiina ^d   Andrulis, Irene L ^e,f   Apicella, Carmel ^g   Arndt, Volker ^h   Barrdahl, Myrto ^h   Benitez, Javier ^i,j   Berg, Christine D ^k   Blomqvist, Carl ^d   Bojesen, Stig E ^l,m   Bonanni, Bernardo ⁿ   Brand, Judith S ^o   Brenner, Hermann ^h   Broeks, Annegien ^p   Burwinkel, Barbara ^h,q   Caldas, Carlos ^a,c,r   Campa, Daniele ^s   Canzian, Federico ^h   Chang Claude, Jenny ^h,t   Chanock, Stephen J ^k   Chin, Suet Feung ^a   Couch, Fergus J ^u   Cox, Angela ^v   Cross, Simon S ^v   Cybulski, Cezary ^w   Czene, Kamila ^o   Darabi, Hatef ^o   Devilee, Peter ^x   Ryan Diver, W ^y   Dunning, Alison M ^a   Earl, Helena M ^c,r   Eccles, Diana M ^z   Ekici, Arif B ^aa   Eriksson, Mikael ^o   Evans, D Gareth ^ab   Fasching, Peter A ^aa,ac   Figueroa, Jonine ^k,ad   Flesch Janys, Dieter ^t   Flyger, Henrik ^l   Gapstur, Susan M ^y   Gaudet, Mia M ^y   Giles, Graham G ^g,ae   Glendon, Gord ^e   Grip, Mervi ^af   Gronwald, Jacek ^w   Haeberle, Lothar ^aa   Haiman, Christopher A ^ag   Hall, Per ^o   Hamann, Ute ^h   Hankinson, Susan ^ah   Hartikainen, Jaana M ^ai,aj   Hein, Alexander ^aa   Hiller, Louise ^ak   Hogervorst, Frans B ^p   Holleczek, Bernd ^al   Hooning, Maartje J ^am   Hoover, Robert N ^k   Humphreys, Keith ^o   Hunter, David J ^b   Hüsing, Anika ^h   Jakubowska, Anna ^w   Jukkola Vuorinen, Arja ^af   Kaaks, Rudolf ^h   Kabisch, Maria ^h   Kataja, Vesa ^ai,an   Knight, Julia A ^e,f   Koppert, Linetta B ^am   Kosma, Veli Matti ^ai,aj   Kristensen, Vessela N ^ap,aq,ar   Lambrechts, Diether ^as,at   Le Marchand, Loic ^au   Li, Jingmei ^o   Lindblom, Annika ^o   Lindström, Sara ^b,av   Lissowska, Jolanta ^aw   Lubinski, Jan ^w   Machiela, Mitchell J ^k   Mannermaa, Arto ^ai,aj   Manoukian, Siranoush ^ax   Margolin, Sara ^o   Marme, Federik ^q   Martens, John W M ^am   McLean, Catriona ^ay   Menéndez, Primitiva ^az   Milne, Roger L ^g,ae   Mulligan, Anna Marie ^ba,bb   Muranen, Taru A ^d   Nevanlinna, Heli ^d   Neven, Patrick ^bc   Nielsen, Sune F ^l   Nordestgaard, Børge G ^l,m   Olson, Janet E ^u   Perez, Jose I A ^az   Peterlongo, Paolo ^br   Phillips, Kelly Anne ^g,ao,bd   Poole, Christopher J ^ak   Pylkäs, Katri ^be,bf   Radice, Paolo ^ax   Rahman, Nazneen ^bg   Rüdiger, Thomas ^bh   Rudolph, Anja ^h   Sawyer, Elinor J ^bi   Schumacher, Fredrick ^bj   Seibold, Petra ^h   Seynaeve, Caroline ^am   Shah, Mitul ^a   Smeets, Ann ^bc   Southey, Melissa C ^bd   Tollenaar, Rob A E M ^x   Tomlinson, Ian ^bk   Tsimiklis, Helen ^bd   Ulmer, Hans Ulrich ^bl   Vachon, Celine ^u   van den Ouweland, Ans M W ^bm   Van't Veer, Laura J ^p   Wildiers, Hans ^bc   Willett, Walter ^b   Winqvist, Robert ^be,bf   Zamora, M Pilar ^bn   Chenevix Trench, Georgia ^bo   Dörk, Thilo ^bp   Easton, Douglas F ^a   García Closas, Montserrat ^k   Kraft, Peter ^b   Hopper, John L ^g   Zheng, Wei ^bq   Schmidt, Marjanka K ^p   Pharoah, Paul D P ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Cambridge Experimental Cancer Medicine Centre   (United Kingdom)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e MOUNT SINAI HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ Structural Biology and Biocomputing Programme   (Spain)

^j CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^k NATIONAL CANCER INSTITUTE   (United States)

^l GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

ⁿ EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^o KAROLINSKA INSTITUTE   (Sweden)

^p ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^q UNIVERSITY OF HEIDELBERG   (Germany)

^r CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^s UNIVERSITY OF PISA   (Italy)

^t UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^u MAYO CLINIC   (United States)

^v UNIVERSITY OF SHEFFIELD   (United Kingdom)

^w POMERANIAN MEDICAL UNIVERSITY   (Poland)

^x LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^y AMERICAN CANCER SOCIETY   (United States)

^z UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^aa UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^ab UNIVERSITY OF MANCHESTER   (United Kingdom)

^ac UNIVERSITY OF CALIFORNIA   (United States)

^ad UNIVERSITY OF EDINBURGH   (United Kingdom)

^ae CANCER EPIDEMIOLOGY CENTRE   (Australia)

^af OULU UNIVERSITY HOSPITAL   (Finland)

^ag UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ah UNIVERSITY OF MASSACHUSETTS   (United States)

^ai UNIVERSITY OF EASTERN FINLAND   (Finland)

^aj KUOPIO UNIVERSITY HOSPITAL   (Finland)

^ak UNIVERSITY OF WARWICK   (United Kingdom)

^al SAARLAND CANCER REGISTRY   (Germany)

^am ERASMUS MC CANCER INSTITUTE   (Netherlands)

^an JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^ao PETER MACCALLUM CANCER CENTRE   (Australia)

^ap OSLO UNIVERSITY HOSPITAL   (Norway)

^aq UNIVERSITY OF OSLO   (Norway)

^ar OSLO UNIVERSITY HOSPITAL   (Norway)

^as DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^at UNIVERSITY OF LEUVEN   (Belgium)

^au UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^av UNIVERSITY OF WASHINGTON   (United States)

^aw INSTITUTE OF ONCOLOGY   (Poland)

^ax NATIONAL CANCER INSTITUTE   (Italy)

^ay ALFRED HOSPITAL   (Australia)

^az HOSPITAL MONTE NARANCO   (Spain)

^ba UNIVERSITY OF TORONTO   (Canada)

^bb UNIVERSITY HEALTH NETWORK   (Canada)

^bc UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bd UNIVERSITY OF MELBOURNE   (Australia)

^be UNIVERSITY OF OULU   (Finland)

^bf Northern Finland Laboratory Centre   (Finland)

^bg INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^bh STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^bi GUY S HOSPITAL   (United Kingdom)

^bj CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bk UNIVERSITY OF OXFORD   (United Kingdom)

^bl Frauenklinik der Stadtklinik Baden Baden   (Germany)

^bm ERASMUS MEDICAL CENTER   (Netherlands)

^bn HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^bo QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^bp HANNOVER MEDICAL SCHOOL   (Germany)

^bq VANDERBILT INGRAM CANCER CENTER   (United States)

^br FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

more..

Author keywords

Body mass index; Breast cancer survival; Epidemiology; Genetics; Mendelian randomization

Indexed keywords

ESTROGEN RECEPTOR;

ANCESTRY; BODY MASS; CANCER; CONFIDENCE INTERVAL; GENETICS; GENOTYPE; REGRESSION ANALYSIS; SURVIVAL; WOMENS HEALTH;

ARTICLE; BODY MASS; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENETIC VARIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENDELIAN RANDOMIZATION ANALYSIS; MENOPAUSE; PRIORITY JOURNAL; SELF REPORT; SMOKING; BREAST TUMOR; CAUCASIAN; CAUSALITY; EPIDEMIOLOGY; EUROPE; GENETICS; META ANALYSIS (TOPIC); MORTALITY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS;

EUROPE;

BODY MASS INDEX; BREAST NEOPLASMS; CAUSALITY; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; META-ANALYSIS AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85039549212     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyx131     Document Type: Article

References (24)

1. World Cancer Research Fund International, Breast cancer statistics. http://www.wcrf.org/int/cancer-facts-figures/data-specific-can cers/breast-cancer-statistics (25May 2016, date last accessed)
2. Guo Q, Schmidt M, Kraft P et al. Identification of novel genetic markers of breast cancer survival. J Natl Cancer Inst 2015;107. doi: 10.1093/jnci/djv081
3. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010;123:627-35
4. Chan DSM, Vieira AR, Aune D et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014;25: 1901-14
5. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-78
6. de Azambuja E, McCaskill-Stevens W, Francis P et al. The effect of body mass index on overall and disease-free survival in nodepositive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG02-98 trial. Breast Cancer Res Treat 2010;119:145-53
7. Imkampe AK, Bates T. Impact of a raised body mass index on breast cancer survival in relation to age and disease extent at diagnosis. Breast J 2010;16:156-61
8. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, Kolonel LN. Obesity and breast cancer survival in ethnically diverse postmenopausal women: The Multiethnic Cohort Study. Breast Cancer Res Treat 2011;129:565-74
9. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003;95:1467-76
10. Dignam JJ, Wieand K, Johnson KA et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptornegative breast cancer. Breast Cancer Res Treat 2006;97:245-54
11. Loi S, Milne RL, Friedlander ML et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2015;14:1686-91
12. Azrad M, Denmark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 2014;3:9-15
13. Copson E, Cutress RI, Maishman T et al. Obesity and the outcome of young breast cancer patients in the UK: the POSH study. Ann Oncol 2015;26:101-12
14. Cecchini R, Swain SM, Costantino JP et al. Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiol Biomarkers Prev. 2016;25; 51-59
15. Pan H, Gray RG. Effect of obesity in premenopausal ER+early breast cancer: EBCTCG data on 80, 000 patients in 70 trials. J Clin Oncol 2014;32 (Suppl):503
16. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22
17. Burgess S, Thompson SG. Mendelian Randomization: Methods for Using Genetic Variants In Causal Estimation. London: Chapman&Hall, 2015
18. Lawlor D, Harbord R, Sterne J, Timpson N Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27: 1133-63
19. Locke AE, Kahali B, Berndt SI et al. Genetic studies of body mass index yield new insights for obesity biology. Nat Genet 2015; 518:197-206
20. Azzato EM, Greenberg D, ShahMet al. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? Br J Cancer 2009;100:1806-11
21. Burgess S, Butterworth A, Thompson SG, Mendelian Randomization Analysis with multiple genetic variants using summarised data. Genet Epidemiol 2013;37:658-65
22. Bowden J, Davey Smith D, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015;44: 512-25
23. Goodwin PJ. Commentary on "Effect of obesity on survival in women with breast cancer: systematic review and metaanalysis" (Melinda Protani, Michael Coory, Jennifer H. Martin). Breast Cancer Res Treat 2010;123:637-40
24. Hsieh FY, Lavori PW. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates. Control Clin Trials 2000;21:552-60